Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: Multi-institution correlation of spectra and identification of biomarkers

被引:75
作者
Rai, AJ
Stemmer, PM
Zhang, Z
Adam, BL
Morgan, WT
Caffrey, RE
Podust, VN
Patel, M
Lim, LY
Shipulina, NV
Chan, DW
Semmes, OJ
Leung, HCE
机构
[1] Johns Hopkins Univ, Dept Pathol, Div Clin Chem, Sch Med, Baltimore, MD 21287 USA
[2] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI USA
[3] Med Coll Georgia, Augusta, GA 30912 USA
[4] Univ Missouri, Div Mol Biol & Biochem, Kansas City, MO 64110 USA
[5] Ciphergen Biosyst, Fremont, CA USA
[6] Genome Inst Singapore, Med Prot & Bioanal Sect, Singapore, Singapore
[7] E Virginia Med Sch, Norfolk, VA USA
关键词
CV; haptoglobin; plasma; SELDI;
D O I
10.1002/pmic.200401320
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report on a multicenter analysis of HUPO reference specimens using SELDI-TOF MS. Eight sites submitted data obtained from serum and plasma reference specimen analysis. Spectra from five sites passed preliminary quality assurance tests and were subjected to further analysis. Intralaboratory CVs varied from 15 to 43%. A correlation coefficient matrix generated using data from these five sites demonstrated high level of correlation, with values > 0.7 on 37 of 42 spectra. More than 50 peaks were differentially present among the various sample types, as observed on three chip surfaces. Additionally, peaks at similar to 9200 and similar to 15950 m/z were present only in select reference specimens. Chromatographic fractionation using anion-exchange, membrane cutoff, and reverse phase chromatography, was employed for protein purification of the similar to 9200 m/z peak. It was identified as the haptoglobin alpha subunit after peptide mass fingerprinting and high-resolution MS/MS analysis. The differential expression of this protein was confirmed by Western blot analysis. These pilot studies demonstrate the potential of the SELDI platform for reproducible and consistent analysis of serum/plasma across multiple sites and also for targeted biomarker discovery and protein identification. This approach could be exploited for population-based studies in all phases of the HUPO PPP.
引用
收藏
页码:3467 / 3474
页数:8
相关论文
共 23 条
[11]   Multi-component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome [J].
Pieper, R ;
Su, Q ;
Gatlin, CL ;
Huang, ST ;
Anderson, NL ;
Steiner, S .
PROTEOMICS, 2003, 3 (04) :422-432
[12]  
Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO
[13]  
2-I
[14]   Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility [J].
Semmes, OJ ;
Feng, Z ;
Adam, BL ;
Banez, LL ;
Bigbee, WL ;
Campos, D ;
Cazares, LH ;
Chan, DW ;
Grizzle, WE ;
Izbicka, E ;
Kagan, J ;
Malik, G ;
McLerran, D ;
Moul, JW ;
Partin, A ;
Prasanna, P ;
Rosenzweig, J ;
Sokoll, LJ ;
Srivastava, S ;
Srivastava, S ;
Thompson, I ;
Welsh, MJ ;
White, N ;
Winget, M ;
Yasui, Y ;
Zhang, Z ;
Zhu, L .
CLINICAL CHEMISTRY, 2005, 51 (01) :102-112
[15]   Efficient and specific removal of albumin from human serum samples [J].
Steel, LF ;
Trotter, MG ;
Nakajima, PB ;
Mattu, TS ;
Gonye, G ;
Block, T .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (04) :262-270
[16]  
TAMMEN H, 2005, PROTEOMICS, V5, DOI DOI 10.1002/PMIC.200400419
[17]   Current developments in SELDI affinity technology [J].
Tang, N ;
Tornatore, P ;
Weinberger, SR .
MASS SPECTROMETRY REVIEWS, 2004, 23 (01) :34-44
[18]   Characterization of the low molecular weight human serum proteome [J].
Tirumalai, RS ;
Chan, KC ;
Prieto, DA ;
Issaq, HJ ;
Conrads, TP ;
Veenstra, TD .
MOLECULAR & CELLULAR PROTEOMICS, 2003, 2 (10) :1096-1103
[19]   Haptoglobin polymorphisms and iron homeostasis in health and in disease [J].
Van Vlierberghe, H ;
Langlois, M ;
Delanghe, J .
CLINICA CHIMICA ACTA, 2004, 345 (1-2) :35-42
[20]   Microparticles in cardiovascular diseases [J].
VanWijk, MJ ;
VanBavel, E ;
Sturk, A ;
Nieuwland, R .
CARDIOVASCULAR RESEARCH, 2003, 59 (02) :277-287